SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 134 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $175,000 | +31.6% | 11,660 | +6.6% | 0.00% | 0.0% |
| Q1 2016 | $133,000 | -81.9% | 10,940 | -76.3% | 0.00% | -75.0% |
| Q4 2015 | $735,000 | +40.5% | 46,210 | +35.5% | 0.00% | +33.3% |
| Q3 2015 | $523,000 | +139.9% | 34,100 | +281.0% | 0.00% | +200.0% |
| Q2 2015 | $218,000 | -81.5% | 8,950 | -82.3% | 0.00% | -85.7% |
| Q1 2015 | $1,177,000 | -7.5% | 50,650 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $1,272,000 | +402.8% | 50,650 | +521.5% | 0.01% | +600.0% |
| Q3 2014 | $253,000 | – | 8,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |